Therefore, variation in KIR and HLA have been thought to affect in the risk of developing cancer [12] Expression of HLA class I molecules is downregulated in more than 70% of colorectal tumors [13], and the prognostic significance of this downregulation has been reported in a large cohort of CRC cases [14]. This evidence concerns the gene KIR3DL1 and colorectal carcinoma.